BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 37371948)

  • 1. Unleashing Ferroptosis in Human Cancers: Targeting Ferroptosis Suppressor Protein 1 for Overcoming Therapy Resistance.
    Lee J; Roh JL
    Antioxidants (Basel); 2023 Jun; 12(6):. PubMed ID: 37371948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis.
    Bersuker K; Hendricks JM; Li Z; Magtanong L; Ford B; Tang PH; Roberts MA; Tong B; Maimone TJ; Zoncu R; Bassik MC; Nomura DK; Dixon SJ; Olzmann JA
    Nature; 2019 Nov; 575(7784):688-692. PubMed ID: 31634900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FSP1 is a glutathione-independent ferroptosis suppressor.
    Doll S; Freitas FP; Shah R; Aldrovandi M; da Silva MC; Ingold I; Goya Grocin A; Xavier da Silva TN; Panzilius E; Scheel CH; Mourão A; Buday K; Sato M; Wanninger J; Vignane T; Mohana V; Rehberg M; Flatley A; Schepers A; Kurz A; White D; Sauer M; Sattler M; Tate EW; Schmitz W; Schulze A; O'Donnell V; Proneth B; Popowicz GM; Pratt DA; Angeli JPF; Conrad M
    Nature; 2019 Nov; 575(7784):693-698. PubMed ID: 31634899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase separation of FSP1 promotes ferroptosis.
    Nakamura T; Hipp C; Santos Dias Mourão A; Borggräfe J; Aldrovandi M; Henkelmann B; Wanninger J; Mishima E; Lytton E; Emler D; Proneth B; Sattler M; Conrad M
    Nature; 2023 Jul; 619(7969):371-377. PubMed ID: 37380771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis.
    Hendricks JM; Doubravsky CE; Wehri E; Li Z; Roberts MA; Deol KK; Lange M; Lasheras-Otero I; Momper JD; Dixon SJ; Bersuker K; Schaletzky J; Olzmann JA
    Cell Chem Biol; 2023 Sep; 30(9):1090-1103.e7. PubMed ID: 37178691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated chemical and genetic screens unveil FSP1 mechanisms of ferroptosis regulation.
    Nakamura T; Mishima E; Yamada N; Mourão ASD; Trümbach D; Doll S; Wanninger J; Lytton E; Sennhenn P; Nishida Xavier da Silva T; Angeli JPF; Sattler M; Proneth B; Conrad M
    Nat Struct Mol Biol; 2023 Nov; 30(11):1806-1815. PubMed ID: 37957306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver Cancer.
    Cheu JW; Lee D; Li Q; Goh CC; Bao MH; Yuen VW; Zhang MS; Yang C; Chan CY; Tse AP; Sit GF; Liu CX; Ng IO; Wong CM; Wong CC
    Cell Mol Gastroenterol Hepatol; 2023; 16(1):133-159. PubMed ID: 36893885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers.
    Koppula P; Lei G; Zhang Y; Yan Y; Mao C; Kondiparthi L; Shi J; Liu X; Horbath A; Das M; Li W; Poyurovsky MV; Olszewski K; Gan B
    Nat Commun; 2022 Apr; 13(1):2206. PubMed ID: 35459868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous regulation of ferroptosis suppressor protein 1 and glutathione peroxidase 4 as a new therapeutic strategy of ferroptosis for esophageal squamous cell carcinoma.
    Miyauchi W; Shishido Y; Matsumi Y; Matsunaga T; Makinoya M; Shimizu S; Miyatani K; Sakamoto T; Umekita Y; Hasegawa T; Fujiwara Y
    Esophagus; 2023 Jul; 20(3):492-501. PubMed ID: 36576648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A non-canonical vitamin K cycle is a potent ferroptosis suppressor.
    Mishima E; Ito J; Wu Z; Nakamura T; Wahida A; Doll S; Tonnus W; Nepachalovich P; Eggenhofer E; Aldrovandi M; Henkelmann B; Yamada KI; Wanninger J; Zilka O; Sato E; Feederle R; Hass D; Maida A; Mourão ASD; Linkermann A; Geissler EK; Nakagawa K; Abe T; Fedorova M; Proneth B; Pratt DA; Conrad M
    Nature; 2022 Aug; 608(7924):778-783. PubMed ID: 35922516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural insights into FSP1 catalysis and ferroptosis inhibition.
    Lv Y; Liang C; Sun Q; Zhu J; Xu H; Li X; Li YY; Wang Q; Yuan H; Chu B; Zhu D
    Nat Commun; 2023 Sep; 14(1):5933. PubMed ID: 37739943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The crystal structure of human ferroptosis suppressive protein 1 in complex with flavin adenine dinucleotide and nicotinamide adenine nucleotide.
    Feng S; Huang X; Tang D; Liu X; Ouyang L; Yang D; Wang K; Liao B; Qi S
    MedComm (2020); 2024 Mar; 5(3):e479. PubMed ID: 38414669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic Intervention Nanoparticles for Triple-Negative Breast Cancer Therapy via Overcoming FSP1-Mediated Ferroptosis Resistance.
    Yang J; Jia Z; Zhang J; Pan X; Wei Y; Ma S; Yang N; Liu Z; Shen Q
    Adv Healthc Mater; 2022 Jul; 11(13):e2102799. PubMed ID: 35395704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute lymphoblastic leukemia necessitates GSH-dependent ferroptosis defenses to overcome FSP1-epigenetic silencing.
    Pontel LB; Bueno-Costa A; Morellato AE; Carvalho Santos J; Roué G; Esteller M
    Redox Biol; 2022 Sep; 55():102408. PubMed ID: 35944469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRIM21-Promoted FSP1 Plasma Membrane Translocation Confers Ferroptosis Resistance in Human Cancers.
    Gong J; Liu Y; Wang W; He R; Xia Q; Chen L; Zhao C; Gao Y; Shi Y; Bai Y; Liao Y; Zhang Q; Zhu F; Wang M; Li X; Qin R
    Adv Sci (Weinh); 2023 Oct; 10(29):e2302318. PubMed ID: 37587773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron Brain Menace: The Involvement of Ferroptosis in Parkinson Disease.
    Lin KJ; Chen SD; Lin KL; Liou CW; Lan MY; Chuang YC; Wang PW; Lee JJ; Wang FS; Lin HY; Lin TK
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FSP1: a key regulator of ferroptosis.
    Li W; Liang L; Liu S; Yi H; Zhou Y
    Trends Mol Med; 2023 Sep; 29(9):753-764. PubMed ID: 37357101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated FSP1 protects KRAS-mutated cells from ferroptosis during tumor initiation.
    Müller F; Lim JKM; Bebber CM; Seidel E; Tishina S; Dahlhaus A; Stroh J; Beck J; Yapici FI; Nakayama K; Torres Fernández L; Brägelmann J; Leprivier G; von Karstedt S
    Cell Death Differ; 2023 Feb; 30(2):442-456. PubMed ID: 36443441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YTHDC1 as a tumor progression suppressor through modulating FSP1-dependent ferroptosis suppression in lung cancer.
    Yuan S; Xi S; Weng H; Guo MM; Zhang JH; Yu ZP; Zhang H; Yu Z; Xing Z; Liu MY; Ming DJ; Sah RK; Zhou Y; Li G; Zeng T; Hong X; Li Y; Zeng XT; Hu H
    Cell Death Differ; 2023 Dec; 30(12):2477-2490. PubMed ID: 37903990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ferroptosis and Its Multifaceted Role in Cancer: Mechanisms and Therapeutic Approach.
    Chen H; Wang C; Liu Z; He X; Tang W; He L; Feng Y; Liu D; Yin Y; Li T
    Antioxidants (Basel); 2022 Jul; 11(8):. PubMed ID: 36009223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.